Cargando…

Tumor board review : guideline and case reviews in oncology /

Praise for the First Edition: "As everyone in oncology fellowship training knows, there is a huge [information] gap in this field. Most oncology books are massive and loaded with information by the time the book is [published] it is outdated." [Tumor Board Review] is fresh and just out of...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Todd, Robert F., III (Editor ), Cooney, Kathleen A. (Editor ), Hayes, Teresa G. (Editor ), Mims, Martha Pritchett (Editor ), Worden, Francis P. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Demos Medical, [2015]
Edición:Second edition.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover; Title; Copyright; Contents; Contributors; Preface to the Second Edition; Preface to the First Edition; Share Tumor Board Review: Guideline and Case Reviews in Oncology, Second Edition; Chapter 1: Head and Neck Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Overview of Staging; Site-Specific Staging for SCCHN; Case Summaries; Locoregionally Advanced Disease; Evidence-Based Case Discussion; Recurrent/Metastatic SCCHN; Evidence-Based Case Discussion; Summary; Review Questions; References; Chapter 2: Thyroid Cancer.
  • Epidemiology, Risk Factors, Natural History, and PathologyDifferentiated Thyroid Carcinoma; Staging; Case Summaries; Early-Stage Papillary Thyroid Cancer: Stage I; Evidence-Based Case Discussion; Differentiated Follicular Thyroid Cancer: Late-Stage Follicular Thyroid Cancer; Evidence-Based Case Discussion; Medullary Thyroid Cancer; Evidence-Based Case Discussion; Anaplastic Thyroid Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 3: Non-Small-Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Early-Stage NSCLC.
  • Evidence-Based Case DiscussionSurgery and Adjuvant Chemotherapy in Early-Stage NSCLC; Regional (Stage III) NSCLC; Evidence-Based Case Discussion; Metastatic NSCLC, Case 1; Evidence-Based Case Discussion; Metastatic NSCLC, Case 2; Evidence-Based Case Discussion; Recurrent NSCLC; Evidence-Based Case Discussion; Review Questions; References; Chapter 4: Small Cell Lung Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; LS-SCLC: Combined Modality Therapy; Evidence-Based Case Discussion; ES-SCLC: Systemic Palliative Therapy; Evidence-Based Case Discussion.
  • Review QuestionsReferences; Chapter 5: Breast Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Ductal Carcinoma In Situ; Early-Stage ER+ Breast Cancer; Early-Stage ER+ Breast Cancer, Stage I or II; Early-Stage TNBC; Locally Advanced HER2+ Breast Cancer; Metastatic Breast Cancer; A Special Note on Breast Cancer in Pregnancy; Review Questions; References; Chapter 6: Esophageal Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries; Locally Advanced Resectable Esophageal Cancer; Evidence-Based Case Discussion.
  • Locally Advanced Unresectable Esophageal CancerEvidence-Based Case Discussion; Metastatic Esophageal Cancer; Evidence-Based Case Discussion; Acknowledgment; Review Questions; References; Chapter 7: Gastric Cancer; Epidemiology, Natural History, Risk Factors, and Pathology; Staging; Case Summaries; Resectable Gastric Cancer; Evidence-Based Case Discussion; Locally Advanced Unresectable and Metastatic Gastric Cancer; Evidence-Based Case Discussion; Review Questions; References; Chapter 8: Pancreatic Cancer; Epidemiology, Risk Factors, Natural History, and Pathology; Staging; Case Summaries.